Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
2021 WS
-
2021 SS
-
2020 WS
-
2020 SS
-
2019 WS
-
2013 WS
-
2013 SS
-
2012 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kineticsIn: Scientific Reports Jg. 13 (2023) Nr. 1,ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarkerIn: Clinical Epigenetics Jg. 15 (2023) Nr. 1,ISSN: 1868-7083; 1868-7075Online Volltext: dx.doi.org/ (Open Access)
-
Choroidal Manifestation of Smoldering Myeloma : Case ReportIn: Klinische Monatsblätter für Augenheilkunde (2022) in pressISSN: 0344-6387; 0023-2165; 1439-3999; 0344-6360Online Volltext: dx.doi.org/
-
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarkerIn: Clinical Epigenetics Jg. 14 (2022) Nr. 1,ISSN: 1868-7083; 1868-7075Online Volltext: dx.doi.org/ (Open Access)
-
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal studyIn: Hematological Oncology (2022) in pressISSN: 0278-0232; 1099-1069Online Volltext: dx.doi.org/ (Open Access)
-
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaIn: Cancers Jg. 14 (2022) Nr. 8,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelIn: Genes, Chromosomes and Cancer Jg. 61 (2022) Nr. 7, S. 432 - 436ISSN: 1098-2264; 1045-2257Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The Biology of Ocular Adnexal Marginal Zone LymphomasIn: Cancers Jg. 14 (2022) Nr. 5,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Human cord blood b cells differ from the adult counterpart by conserved ig repertoires and accelerated response dynamicsIn: Journal of Immunology Jg. 206 (2021) Nr. 12, S. 2839 - 2851ISSN: 1550-6606; 0022-1767Online Volltext: dx.doi.org/ (Open Access)
-
Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infectionsIn: Blood Advances Jg. 5 (2021) Nr. 5, S. 1259 - 1272ISSN: 2473-9537; 2473-9529Online Volltext: dx.doi.org/ (Open Access)
-
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemiaIn: Therapeutic Advances in Hematology Jg. 11 (2020) S. 1 - 15ISSN: 2040-6207; 2040-6215Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencingIn: Cancers Jg. 12 (2020) Nr. 4, S. 986ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Molecular Mechanisms in the Pathogenesis of Composite LymphomasIn: Klinische Pädiatrie Jg. 232 (2020) Nr. 02, S. 80ISSN: 1439-3824; 0300-8630Online Volltext: dx.doi.org/
-
Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemiaIn: European Journal of Haematology Jg. 105 (2020) Nr. 6, S. 786 - 796ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ (Open Access)
-
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemiaIn: Genes, chromosomes & cancer Jg. 59 (2020) Nr. 4, S. 261 - 267ISSN: 1098-2264; 1045-2257Online Volltext: dx.doi.org/ (Open Access)
-
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLLIn: Cancers Jg. 11 (2019) Nr. 12, S. 1833ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individualsIn: Blood Jg. 131 (2018) Nr. 5, S. 546 - 557ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ (Open Access)
-
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaIn: Blood Cancer Journal Jg. 8 (2018) Nr. 1, S. 11ISSN: 2044-5385Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemiaIn: British Journal of Haematology Jg. 173 (2016) Nr. 2, S. 265 - 273ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/
-
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemiaIn: International Journal of Cancer Jg. 138 (2016) Nr. 1, S. 121 - 124ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomasIn: OncoTarget Jg. 7 (2016) Nr. 38, S. 62627 - 62639ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive LymphomasIn: Blood Jg. 126 (2015) Nr. 23,ISSN: 1528-0020; 0006-4971
-
B Cells in Chronically Hepatitis C Virus-Infected Individuals Lack a Virus-Induced Mutation Signature in the TP53, CTNNB1, and BCL6 GenesIn: Journal of Virology Jg. 87 (2013) Nr. 5, S. 2956 - 2962ISSN: 1098-5514; 0022-538XOnline Volltext: dx.doi.org/
-
Next generation transcriptome sequencing confirms the presence of somatic STAT3 mutations and identifies novel TNFAIP3 mutations in T Large Granular Lymphocytic Leukemia (T-LGL)In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 196ISSN: 0378-584X; 1423-0240
-
Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic LeukemiaIn: PLoS ONE Jg. 23 (2013) Nr. 8, S. e72107ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Chronic lymphocytic leukemia gone osteolytic : a case reportIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 217 - 218ISSN: 0378-584X; 1423-0240
-
Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)In: Blood Jg. 120 (2012) Nr. 21, S. 3512ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/
-
Serum immunoglobulin alterations in patients with chronic hepatitis CIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 142 - 143ISSN: 0378-584X; 1423-0240
-
705 Increased prevalence of monoclonal b lymphocytosis in patients with chronic Hepatitis CIn: Journal of Hepatology Jg. 52 (2010) Nr. Suppl. 1, S. S274ISSN: 0168-8278; 1600-0641Online Volltext: dx.doi.org/
-
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemiaIn: Leukemia Research Jg. 34 (2010) Nr. 7, S. 892 - 898ISSN: 1873-5835; 0145-2126Online Volltext: dx.doi.org/
-
Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric ResultsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 58 - S59ISSN: 1439-099X; 0179-7158
-
The CLL-RT1 trial : A multi-center phase-2 trial to evaluate the efficacy and safety of zanubrutinib, a BTK inhibitor, plus tislelizumab, a PD-1 inhibitor, for treatment of patients with Richter Transformation
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 73ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ (Open Access) -
Anti-leukemic activity through CDK9 inhibition in T-cell prolymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 218ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
Gain of STAT3/5 locus is a recurrent cryptic aberration in T-cell prolymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 318ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ (Open Access) -
The DNA-methylation status of BCL11B in T-Cell-Large Granular Lymphocytic Leukemia - a diagnostic target
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 317ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ (Open Access) -
CDK9 Inhibition with LDC526 Is an Effective Treatment for T-Cell Prolymphocytic Leukemia (T-PLL) in VitroIn: Blood Jg. 130 (2017) Nr. Suppl. 1, S. 1262ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/
-
Epigenetic analyses of T-cell large granular lymphocytic leukemia identify differentially methylated enhancer regions leading to deregulation of gene interactionsIn: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 109 - 110ISSN: 2296-5270Online Volltext: dx.doi.org/
-
Genomic profiling of T-cell Prolymphocytic Leukemia (T-PLL) identifies novel recurrent mutations in SAMHD1 and PTPRC
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Leipzig, 14.–18. Oktober 2016,In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 238 - 238ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Percentage of smudge cells on routine blood smears predict time to first treatment and overall survival in patients with Binet stage A chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 139ISSN: 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Polyclonal B-Cell activation and Expansion of Monoclonal B Cells in the Peripheral Blood of Patients with Chronic Hepatitis CIn: Hepatology Jg. 52 (2010) Nr. Suppl. 1, S. 740AISSN: 0270-9139; 1527-3350Online Volltext: dx.doi.org/
-
Prevalence of B cell lymphoproliferative disorders in patients with chronic hepatitis C (CHC)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010, pp 109–206,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 157ISBN: 978-3-8055-9633-6 ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Molekulare Mechanismen und deregulierte Signawege in der Entstehung seltener hämatologischer NeoplasienDuisburg ; Essen (2020) 1 CD-ROM